Skip to content
healthcare.dev

TIZANIDINE

NDC 84386-023, TIZANIDINE, tablet, from Aurobindo Pharma Limited.

Product NDC
84386-023
Status
Listed
Labeler
Aurobindo Pharma Limited
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA076282
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/84386-023 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TIZANIDINE HYDROCHLORIDE2 mg/1

Pharmacologic classes

Adrenergic alpha2-Agonists [MoA]; Central alpha-2 Adrenergic Agonist [EPC]

Package NDCNDC-11Package
84386-023-7784386002377150 TABLET in 1 BOTTLE (84386-023-77)
84386-023-99843860023991000 TABLET in 1 BOTTLE (84386-023-99)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/7ce17c02-7f1f-4d52-8b6f-52e385e12239

Use it

Look up 84386-023 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/84386-023 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 84386-023. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.